Sei sulla pagina 1di 3

Diabetes mellitus and refractive changes: analysis of three cases

and review of the Literature


Necati Duru1 (necatiduru at gmail dot com) #, Dnd Melek Ulusoy2, Aye zkse2, Zeynep Duru3, Hasan
Altnkaynak1, Nilay Yksel1, Mustafa Ata2
1
Ankara Atatrk Education and Research Hospital, Department of Ophthalmology, Turkey. 2 Kayseri Education and
Research Hospital, Department of Ophthalmology, Turkey. 3 Ankara Numune Education and Research Hospital,
Department of Ophthalmology, Turkey
# : corresponding author
DOI
http://dx.doi.org/10.13070/rs.en.1.1169
Date
2014-11-09
Cite as
Research 2014;1:1169
License
CC-BY

Abstract
The human lens has a very sensitive structure, and even small changes in body fluids or eye fluids
can cause changes in the lens. High blood glucose levels are known to cause reversible or
irreversible changes in the labile lens structure and the mechanism of these changes have been
researched extensively. Studies have shown that hyperglycemia causes myopia and hypoglycemia
causes hypermetropia. It is also reported that rapid treatment of diabetes mellitus causes
hypermetropia. In this paper, three cases of refractive changes due to hyperglycemia and insulin
treatment are reviewed, and refractive changes occurring in diabetic patients are discussed with the
data in the literature.
Introduction
It has been known for years that high blood glucose levels cause reversible or irreversible changes
in the labile lens structure. A lot of studies were conducted to research the mechanism of these
changes [1] [2] [3]. It is reported that short or long term changes in blood glucose level especially
affect refractive values. In hyperglycemia, hypermetropia or myopia, and in hypoglycemia,
hypermetropia was observed. Also, hypermetropia could occur in cases in which blood glucose level
is reduced a great deal [4] [5]. These changes are important clinically in refractive examination. For
this reason, we address the question of 'when is it appropriate for refractive examination to be
performed in diabetic patients?'
In this article, three cases who developed refractive changes because of hyperglycemia and insulin
treatment were reviewed with the aim of discussing refractive changes occurring in diabetic patients
with the data in the literature.
Case Reports
Case 1

Fifty-nine-year-old male patient presented to ophthalmology outpatient clinic with the complaint of
blurry vision. It was learned that he changed his eyeglasses two times in the last six months and his
vision was impaired more in recent times. His eyeglasses were -2.50 dioptre (D) in right, and -2.25 D
in left eye. In the visual acuity examination, his visual acuity was 20/20 with -3.00 D in right and -2.75
D in left eye. Anterior and posterior segment examination of patient was normal bilaterally. The
patient was referred to an internal medicine doctor because of the fact that refractive change of

patient in a short time might be related to diabetes mellitus. Blood glucose level was measured as
592 mg/ml and patient diagnosed with diabetes was hospitalised by endocrinologist. Insulin therapy
was started to patient and blood glucose level was regulated. The patient presented to the
opthalmology outpatient clinic three days later, and he offered that he saw better without his
eyeglasses and he had difficulty in near vision. His refraction was measured as +0.50 D in right and
as +0.75 D in left eye. His visual acuity was 20/20 bilaterally without refractive correction. When
blood glucose level was regulated, refractive examination of patient was the same in the first week,
first month, and second month after diagnosis of diabetes mellitus.
Case 2

Fifty-two-year-old male patient presented to ophthalmology outpatient clinic with the complaint of
blurry vision. His eyeglasses used for one year were -1.00 D in right and -1.25 D in left. Visual acuity
was 20/20 bilaterally with +3.00 D glass in right and with +3.50 D in left eye. He reported that he was
diagnosed with diabetes mellitus one week ago and he began to receive insulin therapy. Refractive
change was thought related to insulin therapy and patient was called for control two weeks later.
Visual acuity was 20/20 in control examination with +4.00 D in right and with +4.25 D in left eye.
Refraction was +0.75 D in both eyes in the first month control examination, and it was +0.25 D in
right eye and +0.50 D in left eye in the second month control.
Case 3

Fifty-six-year-old female patient was referred to ophthalmology outpatient clinic for fundus
examination. Her blood glucose level was 390 mg/ml. She said that she had not any visual problem
except impaired near vision. However, she reported that she had had some problems in far vision
and better near vision for the last month. Her visual acuity was 20/20 in both eyes with -2.00 D
refractive correction. Anterior and posterior segment examination was also normal. The refractive
change in such a short time was thought related to hyperglycemia, and patient was called two weeks
later for control. She said that she had near vision problems again in control two weeks later. She
said that she started to use insulin and her blood glucose level was regulated. Refractive values
were +1.50 D in right eye and +1,00 D in left eye. Her refractive measurement was +0.50 D in right,
and there was no refractive error in left eye in examination two months later.
Discussion
Although oxidative mechanisms are thought to be responsible for cataract formation in diabetic
patients, refractive changes are mostly related to osmotic fluctuations. In a hyperosmotic media,
firstly, lens volume decreases. Then, lens volume begins to increase with inflow of glucose and water
into the lens. Simultaneously, permeability of lens to K+ increases. When osmolarity decreases,
glucose entered into lens continues to pull water from outside of the lens, and volume increase of
lens doesn't stop immediately. Lastly, decrease in volume occurs only when glucose exits the
lens [6].
The changes in lens affect refraction in these ways: In the beginning of hyperglycemia,
hypermetropia occurance is observed for a short time because of decrease in lens volume, and
myopia occurs when lens volume starts to increase. When blood glucose level reduces rapidly,
hypermetropia is seen related with decrease in lens thickness and refractive index. After regulation
of blood glucose level, lens thickness decreases and hypermetropia is seen. Hypermetropia
occuring in the first days after beginning of treatment comes to balance within one month [5] [7].
Saito et al. reported that hypermetropia occured immediately after the beginning of treatment
because of the decrease in refractive index related to water entering into the lens in their study
involving diabetic patients [5]. Similarly, Snmez et al. reported that hypermetropia was observed
generally in diabetic patients when treatment was started and blood glucose began to decrease [8].
Gwinup et al. found that intravenous injection of glucose solution caused myopia in phakic diabetic
patients and hypermetropia in aphakic diabetic patients in their study [9]. Similarly, Furushima et al.
showed that induced hyperglycemia caused myopia in their study involving healthy individuals [10].
Contrary to these studies showing hyperglycemia caused myopia, Tai et al. established that
hypermetropia occured during hyperglycemia [11].
Furthermore, it was reported that changes occuring in the cornea could cause refractive alterations
apart from functional and morphological changes in lens in diabetic patients. Repeated corneal

erosions, healed corneal epithelial defects and changes in corneal endothelium are the principal
reasons of refractive alterations [12] [13][14] [15]. Also it was showed that high glucose
concentrations in the aquous humor and cornea could change corneal topography by affecting
corneal hydration [8] [16] [17].
In our study, myopic alteration was observed related to hyperglycemia in three cases. Then,
refractive changes towards hypermetropia were observed when blood glucose decreased rapidly
with insulin therapy, and in the second month, stable refractive error was proved.
Conclusion
Consequently; it is known that diabetic patients have more complaints about their eyeglasses.
Understanding the clinical progress of these cases is so important for appropriate refractive
examination of them.
Declarations
Financial Disclosure

No author has a financial or proprietary interest in any material or method mentioned


References
1.
Malone J, Lowitt S, Cook W. Nonosmotic diabetic cataracts. Pediatr Res. 1990;27:293-6 pubmed
2.
Unakar N, Tsui J. Inhibition of galactose-induced alterations in ocular lens with sorbinil. Exp Eye Res.
1983;36:685-94 pubmed
3.
Brown C, Burman D. Transient cataracts in a diabetic child with hyperosmolar coma. Br J Ophthalmol.
1973;57:429-33 pubmed
4.
Duke-Elders: System of Ophthalmology. London: Kimpton. 1990;5:368-573.
5.
Saito Y, Ohmi G, Kinoshita S, Nakamura Y, Ogawa K, Harino S, et al. Transient hyperopia with lens swelling
at initial therapy in diabetes. Br J Ophthalmol. 1993;77:145-8 pubmed
6.
Jacob T, Duncan G. Glucose-induced membrane permeability changes in the lens. Exp Eye Res.
1982;34:445-53 pubmed
7.
Okamoto F, Sone H, Nonoyama T, Hommura S. Refractive changes in diabetic patients during intensive
glycaemic control. Br J Ophthalmol. 2000;84:1097-102 pubmed
8.
Sonmez B, Bozkurt B, Atmaca A, Irkec M, Orhan M, Aslan U. Effect of glycemic control on refractive
changes in diabetic patients with hyperglycemia. Cornea. 2005;24:531-7 pubmed
9.
Gwinup G, Villarreal A. Relationship of serum glucose concentration to changes in refraction. Diabetes.
1976;25:29-31 pubmed
10.
Furushima M, Imaizumi M, Nakatsuka K. Changes in refraction caused by induction of acute hyperglycemia
in healthy volunteers. Jpn J Ophthalmol. 1999;43:398-403 pubmed
11.
Tai M, Lin S, Chen J, Liang C, Chou P, Lu D. Sweet hyperopia: refractive changes in acute hyperglycemia.
Eur J Ophthalmol. 2006;16:663-6 pubmed
12.
Tsubota K, Chiba K, Shimazaki J. Corneal epithelium in diabetic patients. Cornea. 1991;10:156-60 pubmed
13.
Larsson L, Bourne W, Pach J, Brubaker R. Structure and function of the corneal endothelium in diabetes
mellitus type I and type II. Arch Ophthalmol. 1996;114:9-14 pubmed
14.
Taylor H, Kimsey R. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci.
1981;20:548-53pubmed
15.
McNamara N, Brand R, Polse K, Bourne W. Corneal function during normal and high serum glucose levels
in diabetes. Invest Ophthalmol Vis Sci. 1998;39:3-17 pubmed
16.
Herse P. Corneal hydration control in normal and alloxan-induced diabetic rabbits. Invest Ophthalmol Vis
Sci. 1990;31:2205-13pubmed
17.
Wilson S, Ambrosio R. Computerized corneal topography and its importance to wavefront technology.
Cornea. 2001;20:441-54pubmed
ISSN : 2334-1009

Topics

type 2 diabetes mellitus

ocular refraction

Potrebbero piacerti anche